TuHURA Biosciences Inc.

HURA | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.14

-$0.04 (-1.83%)

Sep 22, 2026, 12:48 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.83%

(1D)

Rating

Updated: Sep 8, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $136.28M

1D Range

2.13 2.22

52W Range

0.41 3.43

Valuation (TTM)

PE -4.04

PB 7.50

EV/EBITDA -4.70

Valuation (NTM)

Forward PE N/A

Forward PEG -0.34

Price Target $9

Cash Flow

FCF Yield -21.5%

SBC Adj. FCF Yield -25.7%

SBC Impact -19.2%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 142.5% | 81.5%

FCF 3Y | 5Y -54.7% | -14.8%

Returns

ROA -96.5%

ROE -154.3%

ROIC -137.4%

Financial Health

Net Cash

$588.95K

Current Ratio 0.18

Interest Coverage -27.83

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies des...

Sector Healthcare

Industry Biotechnology

Employees 22

IPO Date Feb 21, 2013

Website www.tuhurabio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+320.56%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞